Baseline | 12 weeks supplementation | 24 weeks supplementation | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Supplementation group | Placebo group | Supplementation group | Placebo group | CI of group difference2-150 | Supplementation group | Placebo group | CI of group difference2-150 | p value of the group factor2-160 | |||
FEV1 (% pred) | 72.2 (32.2) | 83.7 (21.1) | 71.6 (34.0) | 82.2 (15.1) | –10.17 to 5.66 | 70.0 (33.3) | 80.3 (19.1) | –9.40 to 7.650 | 0.696 | ||
Antibiotic days/patient | 14.5 (14.9) | 10.5 (11.2) | 9.8 (10.3) | 24.8 (19.1) | –35.5 to –2.23 | 10.5 (9.9) | 18.5 (15.8) | –26.73 to 3.07 | 0.050 | ||
Total antioxidative capacity (nmol) | 0.85 (0.34) | 0.86 (0.26) | 0.96 (0.19) | 0.87 (0.21) | –0.003 to 0.607 | 0.93 (0.22) | 0.90 (0.19) | –0.204 to 0.346 | 0.196 |